Shandong push the high-quality development of biomedicine, the scale of medicine accounted for one-seventh of the country

"Pharmaceutical Network Industry Dynamics" Has always been the focus of the development of strategic emerging industries in Shandong Province, such as from the 13th Five-Year Plan period of the "seven strategic emerging industries" to the establishment of the "Top Ten Industries" in the medical and health sector, Shandong Province in marine drugs, biotechnology drugs, modernization of traditional Chinese medicine, new medical devices and other industrial areas have made great progress.
In recent years, Shandong Province's pharmaceutical industry is accelerating high-quality development, now high-end platform gathering, pharmaceutical science and technology support capacity, with 21 national pharmaceutical innovation platform, drug safety evaluation research center 5, drug clinical trial institutions 61, 4 first batch of the National Drug Administration key laboratories, pharmaceutical industry scale accounted for one-seventh of the country, 13 enterprises into the national pharmaceutical enterprises.
high-quality development of the biopharmaceutical industry, Shandong Province has also introduced a new policy.
the beginning of this year in Qingdao, Shandong Province, "on supporting the high-quality development of the biopharmaceutical industry a number of policy measures notice" for the city's biopharmaceutical industry sent a "policy dividend."
that these initiatives cover the whole biopharmaceutical industry chain, such as new drug research and development, industrialization, project investment, platform construction, market sales, etc., which encourages industrial innovation to become a bright spot.
According to the notice, in encouraging research and development innovation, it will provide up to 1 million yuan per grant for the completion of preclinical studies and the obtaining of clinical acceptance numbers or default clinical treatments for class 1 chemicals, biological products, Chinese medicines and natural medicines.
Medical health is one of Shandong's "top ten" industries, in order to build a trillion-level pharmaceutical industry group, Shandong Province has issued a series of encouraging and supporting policies, focusing on the cultivation of Jinan High-tech Zone, Yantai Development Zone, Luze High-tech Zone and other 14 biopharmaceutical industry clusters, a large number of well-known enterprises in the field of medicine emerged.
In particular, Jinan Biopharmaceutical Industry business revenue has exceeded 100 billion yuan, and proposed plans to increase to 200 billion yuan in 2022;
Jinan has issued a series of policies to the newly introduced domestic and foreign advanced talents and teams, subsidies up to 100 million yuan, to eligible biopharmaceutical enterprises, according to the annual actual research and development investment of 15% of the subsidy, the newly obtained national class of new drugs for each product a one-time award of 20 million yuan.
such as Yantai, in recent years, the biopharmaceutical industry has become a strategic emerging industry that Yantai has focused on building, forming an industrial pattern covering research and development and manufacturing in the fields of biopharmaceuticals, chemicals, modern Chinese medicine and medical devices.
Yantai Development Zone alone has gathered Rongchang Pharmaceuticals, Dongcheng Pharmaceuticals, Sonic Bio, Zhenghai Bio, Progi and other more than 100 enterprises.
By Yantai Development Zone Management Committee and Rongchang Pharmaceutical co-funded the creation of the Industryda International Biopharmaceutical Innovation Incubation Center, since its inception to attract domestic and foreign outstanding innovative start-up enterprises and projects, the current market value of incubators has exceeded 300 million yuan.
, Shandong attaches great importance to the development of biopharmaceutical industry, in policy, technology, talent, capital and other aspects for the development of biomedicine to create a good environment.
In order to better promote the high-quality development of Shandong biopharmaceutical industry, some people in the industry said that to further strengthen the coordination of industry, science and research, the establishment of a good industrial chain ecology, which is to complement the public health industry short board, promote the high-quality development of Shandong pharmaceutical industry fundamental measures.